LI Yang-yang, LIU Hua, LIU Hong, ZHANG Yong-qiang, ZHANG Wan-nian, SHENG Chun-quan. Design, synthesis and antifungal activity of novel triazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(1): 27-31. doi: 10.3969/j.issn.1006-0111.2013.01.008
Citation:
|
LI Yang-yang, LIU Hua, LIU Hong, ZHANG Yong-qiang, ZHANG Wan-nian, SHENG Chun-quan. Design, synthesis and antifungal activity of novel triazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(1): 27-31. doi: 10.3969/j.issn.1006-0111.2013.01.008
|
Design, synthesis and antifungal activity of novel triazole derivatives
- 1.
Department of Medicinal Chemistry, Jiangxi institute of traditional Chinese medicine, Nanchang 330006, China
- 2.
Department of Medicinal Chemistry, Second Military Medicinal University, Shanghai 200433, China
- Received Date: 2012-06-01
- Rev Recd Date:
2012-09-21
-
Abstract
Objective To design the novel triazole derivatives and test their in vitro antifungal activities on the basis of the molecular design model for rational optimization of azole drugs. Methods Ring-open reaction of the oxiranes was used to synthesize the target compounds, whose chemical structures were confirmed by 1H NMR and MS. Serial dilution method was used to determine the in vitro antifungal activities. Results Two novel azole compounds containing trizaolone side chains were synthesized which showed excellent and broad-spectrum antifungal activity. Conclusion The targeted compounds showed better antifungal activity against Candida albicans than the positive drugs fluconazole and ketoconazole, which was worth to further investigate the structure-activity relationship.
-
References
[1]
|
Sheng C, Zhang W. New Lead Structures in Antifungal Drug Discovery[J]. Curr Med Chem,2011, 18(5): 733. |
[2]
|
Borate HB, Maujan SR, Sawargave SP, et al. Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents[J]. Bioorg Med Chem Lett,2010, 20(2):722. |
[3]
|
Guillon R, Pagniez F, Rambaud C, et al. Design, synthesis, and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3- (1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships[J]. Chem Med Chem,2011, 6(10):1806. |
[4]
|
Guillon R, Pagniez F, Giraud F, et al. Design, synthesis, and in vitro antifungal activity of 1-[(4-substituted-benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols[J].Chem Med Chem,2011, 6(5):816. |
[5]
|
Sheng C, Zhang W, Zhang M, et al. Homology Modeling of Lanosterol 14-Demethylase of Candida albicans and Aspergillus fumigatus and Insights into the Enzyme-Substrate Interactions[J]. J Biomol Struct & Dyn, 2004, 22(1):91. |
[6]
|
Sheng C, Wang W, Che X, et al. Improved Model of Lanosterol 14alpha-Demethylase by LigandSupported Homology Modeling: Validation by Virtual Screening and Azole Optimization[J]. Chem Med Chem,2010, 5(3): 390. |
[7]
|
Sheng C, Miao Z, Ji H, Threedimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: activesite characterization and insights into azole binding. Antimicrob Agents[J].Chemother,2009, 53(8):3487. |
[8]
|
Sheng C, Zhang W, Ji H, et al. Structure-based Optimization of Azole Antifungal Agents by CoMFA, CoMSIA and Molecular Docking[J]. J Med Chem, 2006, 49(8):2512. |
-
-
Proportional views
-